Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
| Also see Pharma Marketing News OpEd Pieces |
Plan B FDAgate
Posted: November 15, 2005FDA's decision to block approval of OTC status for the Plan B contraceptive is rapidly becoming the center of an FDA controversy that has all the earmarks of a Watergate conspiracy. At the center of the controversy is a report by the non-partisan Government Accountability Office (GAO) released yesterday to Congress.Read more about this in today's post to Pharma Marketing Blog.